menu
    • menu

    Company profile for Adicet Bio

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Harnessing the power of the immune system to treat cancer and other diseases Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases. Adicet is developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors (CARs) or T Cell Receptors (TCR...
    Harnessing the power of the immune system to treat cancer and other diseases Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases. Adicet is developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors (CARs) or T Cell Receptors (TCRs). Adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating TCR-like MAbs (TCRLs) directed to these cancer-specific peptide targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adicet BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Constitution Drive Menlo Park, CA 94025
    Telephone
    Telephone
    (650) 542-0034
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adicetbio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/adicet-bio-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adicet Bio To Present At Guggenheim Biotech Summit 2026
    Adicet Bio To Present At Guggenheim Biotech Summit 2026

    30 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260130979631/en/Adicet-Bio-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026

    BUSINESSWIRE
    30 Jan 2026
    Share Share
    Adicet Bio Updates On Corporate Progress, 2026 Milestones
    Adicet Bio Updates On Corporate Progress, 2026 Milestones

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/adicet-bio-provides-corporate-update-and-highlights-expected-2026-milestones

    PHARMIWEB
    07 Jan 2026
    Share Share
    Adicet Bio Announces Reverse Stock Split
    Adicet Bio Announces Reverse Stock Split

    26 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251226661793/en/Adicet-Bio-Announces-Reverse-Stock-Split

    BUSINESSWIRE
    26 Dec 2025
    Share Share
    Adicet Bio Discloses Inducement Grant Per Nasdaq LR 5635(C)(4)
    Adicet Bio Discloses Inducement Grant Per Nasdaq LR 5635(C)(4)

    28 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251128794647/en/Adicet-Bio-Reports-Inducement-Grant-under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    28 Nov 2025
    Share Share
    Adicet Bio Unveils Q3 2025 Financials & Business Updates
    Adicet Bio Unveils Q3 2025 Financials & Business Updates

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105901973/en/Adicet-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    Adicet Bio Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Adicet Bio Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031278051/en/Adicet-Bio-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    31 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search